MYGN logo

Myriad Genetics (MYGN) Non Current Assets

Annual Non Current Assets

$832.90 M
-$91.20 M-9.87%

01 December 2023

MYGN Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Non Current Assets

$788.10 M
-$5.40 M-0.68%

01 September 2024

MYGN Quarterly Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

MYGN Non Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-9.9%-10.8%
3 y3 years-19.1%-5.8%
5 y5 years-31.4%-37.5%

MYGN Non Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-19.1%at low-14.7%at low
5 y5 years-31.4%at low-37.5%at low
alltimeall time-31.4%+3974.2%-37.5%+6753.0%

Myriad Genetics Non Current Assets History

DateAnnualQuarterly
Sept 2024
-
$788.10 M(-0.7%)
June 2024
-
$793.50 M(-3.3%)
Mar 2024
-
$820.20 M(-1.5%)
Dec 2023
$313.60 M(+14.2%)
$832.90 M(-5.7%)
Sept 2023
-
$883.70 M(-1.0%)
June 2023
-
$892.90 M(-1.6%)
Mar 2023
-
$907.70 M(-1.8%)
Dec 2022
$274.60 M(-43.4%)
$924.10 M(+7.5%)
Sept 2022
-
$859.70 M(+2.0%)
June 2022
-
$843.10 M(+1.8%)
Mar 2022
-
$828.00 M(-0.9%)
Dec 2021
$484.80 M(+24.5%)
$835.90 M(-0.1%)
Sept 2021
-
$837.00 M(+1.9%)
June 2021
-
$821.40 M(-18.5%)
Mar 2021
-
$1.01 B(-4.0%)
Dec 2020
$389.40 M(+17.4%)
-
Sept 2020
-
$1.05 B(-2.1%)
June 2020
$331.70 M(-4.8%)
$1.07 B(-1.7%)
Mar 2020
-
$1.09 B(-10.0%)
Dec 2019
-
$1.21 B(-3.9%)
Sept 2019
-
$1.26 B(+3.9%)
June 2019
$348.60 M(+6.4%)
$1.21 B(-0.0%)
Mar 2019
-
$1.21 B(-0.4%)
Dec 2018
-
$1.22 B(-1.0%)
Sept 2018
-
$1.23 B(+45.3%)
June 2018
$327.60 M(+8.6%)
$847.70 M(-4.4%)
Mar 2018
-
$887.00 M(-1.6%)
Dec 2017
-
$901.50 M(-0.1%)
Sept 2017
-
$902.70 M(-0.5%)
June 2017
$301.70 M(-4.1%)
$907.20 M(-1.3%)
Mar 2017
-
$919.50 M(-1.6%)
Dec 2016
-
$934.50 M(-1.4%)
Sept 2016
-
$948.00 M(+67.5%)
June 2016
$314.50 M(+10.9%)
$566.00 M(+14.2%)
Mar 2016
-
$495.80 M(-0.1%)
Dec 2015
-
$496.20 M(+3.4%)
Sept 2015
-
$479.70 M(-0.6%)
June 2015
$283.60 M(-12.0%)
$482.60 M(-2.8%)
Mar 2015
-
$496.63 M(+7.5%)
Dec 2014
-
$461.77 M(-2.5%)
Sept 2014
-
$473.64 M(-5.5%)
June 2014
$322.40 M(-33.4%)
$501.40 M(+4.8%)
Mar 2014
-
$478.26 M(+58.3%)
Dec 2013
-
$302.18 M(-6.4%)
Sept 2013
-
$322.98 M(+1.0%)
June 2013
$483.99 M(+14.6%)
$319.83 M(+13.7%)
Mar 2013
-
$281.32 M(+8.0%)
Dec 2012
-
$260.41 M(-2.8%)
Sept 2012
-
$267.93 M(-0.1%)
June 2012
$422.49 M(+1.0%)
$268.14 M(-4.4%)
Mar 2012
-
$280.58 M(+22.6%)
Dec 2011
-
$228.82 M(+13.7%)
Sept 2011
-
$201.26 M(+4.5%)
June 2011
$418.26 M(-11.8%)
$192.57 M(+35.9%)
Mar 2011
-
$141.67 M(-4.8%)
Dec 2010
-
$148.80 M(+25.0%)
Sept 2010
-
$119.00 M(-0.7%)
June 2010
$473.98 M
$119.87 M(-13.7%)
DateAnnualQuarterly
Mar 2010
-
$138.94 M(-0.2%)
Dec 2009
-
$139.19 M(+66.1%)
Sept 2009
-
$83.78 M(-16.4%)
June 2009
$366.12 M(-3.0%)
$100.27 M(-38.8%)
Mar 2009
-
$163.86 M(-16.7%)
Dec 2008
-
$196.65 M(+18.7%)
Sept 2008
-
$165.67 M(+35.8%)
June 2008
$377.30 M(+49.4%)
$122.04 M(-11.6%)
Mar 2008
-
$138.01 M(-10.9%)
Dec 2007
-
$154.86 M(+10.2%)
Sept 2007
-
$140.47 M(+14.2%)
June 2007
$252.53 M(+0.1%)
$123.01 M(+348.6%)
Mar 2007
-
$27.42 M(-1.9%)
Dec 2006
-
$27.95 M(+11.8%)
Sept 2006
-
$25.01 M(+2.9%)
June 2006
$252.29 M(+86.1%)
$24.32 M(+0.2%)
Mar 2006
-
$24.27 M(+3.6%)
Dec 2005
-
$23.42 M(+3.3%)
Sept 2005
-
$22.67 M(-3.1%)
June 2005
$135.56 M(-1.2%)
$23.40 M(-60.9%)
Mar 2005
-
$59.81 M(-3.7%)
Dec 2004
-
$62.13 M(+0.1%)
Sept 2004
-
$62.10 M(+21.4%)
June 2004
$137.19 M(+33.4%)
$51.16 M(-6.7%)
Mar 2004
-
$54.81 M(-16.8%)
Dec 2003
-
$65.87 M(-2.9%)
Sept 2003
-
$67.85 M(-15.2%)
June 2003
$102.82 M(+20.5%)
$80.00 M(+29.7%)
Mar 2003
-
$61.69 M(-2.8%)
Dec 2002
-
$63.45 M(-6.3%)
Sept 2002
-
$67.73 M(-6.0%)
June 2002
$85.35 M(-37.8%)
$72.04 M(+16.7%)
Mar 2002
-
$61.74 M(+4.5%)
Dec 2001
-
$59.07 M(+6.2%)
Sept 2001
-
$55.62 M(+59.1%)
June 2001
$137.20 M(+59.7%)
$34.95 M(+21.5%)
Mar 2001
-
$28.77 M(-25.5%)
Dec 2000
-
$38.64 M(+21.3%)
Sept 2000
-
$31.86 M(+55.8%)
June 2000
$85.93 M(+527.2%)
$20.44 M(+1.0%)
Mar 2000
-
$20.24 M(-23.6%)
Dec 1999
-
$26.50 M(-20.7%)
Sept 1999
-
$33.40 M(-16.3%)
June 1999
$13.70 M(-56.8%)
$39.90 M(-6.6%)
Mar 1999
-
$42.70 M(+20.3%)
Dec 1998
-
$35.50 M(-21.5%)
Sept 1998
-
$45.20 M(+26.6%)
June 1998
$31.70 M(-34.8%)
$35.70 M(-6.3%)
Mar 1998
-
$38.10 M(+36.6%)
Dec 1997
-
$27.90 M(+21.3%)
Sept 1997
-
$23.00 M(-16.4%)
June 1997
$48.60 M(-4.0%)
$27.50 M(-16.2%)
Mar 1997
-
$32.80 M(-2.1%)
Dec 1996
-
$33.50 M(+31.9%)
Sept 1996
-
$25.40 M(-12.4%)
June 1996
$50.60 M
$29.00 M(-0.7%)
Mar 1996
-
$29.20 M(+153.9%)
Dec 1995
-
$11.50 M

FAQ

  • What is Myriad Genetics annual long term assets?
  • What is the all time high annual non current assets for Myriad Genetics?
  • What is Myriad Genetics annual non current assets year-on-year change?
  • What is Myriad Genetics quarterly long term assets?
  • What is the all time high quarterly non current assets for Myriad Genetics?
  • What is Myriad Genetics quarterly non current assets year-on-year change?

What is Myriad Genetics annual long term assets?

The current annual non current assets of MYGN is $832.90 M

What is the all time high annual non current assets for Myriad Genetics?

Myriad Genetics all-time high annual long term assets is $1.21 B

What is Myriad Genetics annual non current assets year-on-year change?

Over the past year, MYGN annual long term assets has changed by -$91.20 M (-9.87%)

What is Myriad Genetics quarterly long term assets?

The current quarterly non current assets of MYGN is $788.10 M

What is the all time high quarterly non current assets for Myriad Genetics?

Myriad Genetics all-time high quarterly long term assets is $1.26 B

What is Myriad Genetics quarterly non current assets year-on-year change?

Over the past year, MYGN quarterly long term assets has changed by -$95.60 M (-10.82%)